Enhanced Tumor Uptake of Macromolecules Induced by a Novel Vasoactive Interleukin 2 Imrnunoconjugate1 (original) (raw)
Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2
Clive Taylor
Cancer research, 1995
View PDFchevron_right
Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules
Paolo A Netti
Proceedings of the National Academy of Sciences of the United States of America, 1999
View PDFchevron_right
Systemic perfusion: a method of enhancing relative tumor uptake of radiolabeled monoclonal antibodies
Onelio Geatti
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
View PDFchevron_right
Effect of increasing vascular hydraulic conductivity on delivery of macromolecular drugs to tumor cells
Timothy Secomb
International Journal of Radiation Oncology*Biology*Physics, 1995
View PDFchevron_right
Influence of vasoactive drugs on local tumor blood flow
Jan Mattsson
European Journal of Cancer and Clinical Oncology, 1982
View PDFchevron_right
Modification of tumor blood flow: Current status and future directions
Gillian Tozer
Seminars in Radiation Oncology, 1998
View PDFchevron_right
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
Napoleone Ferrara
Proceedings of the National Academy of Sciences, 1996
View PDFchevron_right
Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability
R. Kashi
International Journal of Cancer, 1995
View PDFchevron_right
Use of Antibody as Carrier of Oligomers of Peptidomimetic α v β 3 Antagonist to Target Tumor-Induced Neovasculature
King Li
Bioconjugate Chemistry, 2007
View PDFchevron_right
Effect of Inhibition of Vascular Endothelial Growth Factor Signaling on Distribution of Extravasated Antibodies in Tumors
D. Hu-Lowe
Cancer Research, 2006
View PDFchevron_right
Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors
T. Shockley
Cancer research, 1992
View PDFchevron_right
Identification of a Monoclonal Antibody, TV1, Directed against the Basement Membrane of Tumor Vessels, and Its Use to Enhance the Delivery of Macromolecules to Tumors after Conjugation with Interleukin 21
Clive Taylor, Jason Hornick
2000
View PDFchevron_right
Bevacizumab-Induced Vessel Normalization Hampers Tumor Uptake of Antibodies--Response
Sjoukje Oosting
Cancer Research, 2013
View PDFchevron_right
Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumors
Bruce Fenton
Radiotherapy and Oncology, 2004
View PDFchevron_right
Vascular Permeability and Drug Delivery in Cancers
jagoda hebda
Frontiers in Oncology, 2013
View PDFchevron_right
Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue
Terry Jones
Molecular Cancer Therapeutics, 2009
View PDFchevron_right
The mechanistic immunosuppressive role of the tumour vasculature and potential nanoparticle-mediated therapeutic strategies
Jale Yuzugulen
Frontiers in Immunology
View PDFchevron_right
Short-period-induced hypertension could improve tumor-to-nontumor ratios of radiolabeled monoclonal antibody
Takatoshi Michigishi
Nuclear Medicine and Biology, 1997
View PDFchevron_right
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate
Luciano Zardi
International Journal of Cancer, 2006
View PDFchevron_right
Antibody drug-conjugates targeting the tumor vasculature: Current and future developments
Hans-peter Gerber
mAbs
View PDFchevron_right
Antitumor Effects of a Monoclonal Antibody that Binds Anionic Phospholipids on the Surface of Tumor Blood Vessels in Mice
Douglas Scothorn
Clinical Cancer Research, 2005
View PDFchevron_right
Tumor blood vessels, a difficult hurdle for infiltrating leukocytes
Arjan Griffioen
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007
View PDFchevron_right
High Interstitial Fluid Pressure Is Associated with Low Tumour Penetration of Diagnostic Monoclonal Antibodies Applied for Molecular Imaging Purposes
Markus Heine
PLoS ONE, 2012
View PDFchevron_right
Kinetics of Radioiodinated Monoclonal antibodies in the Rat: Influence of Tumour Growth and Reticuloendothelial System Host Modulation
Lars Jacobsson
Acta Oncologica, 1989
View PDFchevron_right
Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow
Lisa Ridnour
Neoplasia, 2008
View PDFchevron_right
The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy
Wijnand Helfrich
Journal of Controlled Release, 2000
View PDFchevron_right
Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors
Peisheng Hu
Clinical cancer research : an official journal of the American Association for Cancer Research, 1999
View PDFchevron_right
A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratio
Sven-erik Strand
Cancer, 1994
View PDFchevron_right
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes
Matteo Bellone
Frontiers in oncology, 2013
View PDFchevron_right
Won’t you come on in? How to favor lymphocyte infiltration in tumors
Matteo Bellone
OncoImmunology, 2012
View PDFchevron_right
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
David Needham
JNCI Journal of the National Cancer Institute, 2006
View PDFchevron_right